Company Overview | Monexa AI | Monexa

AURA Financial Overview

Comprehensive financial analysis and stock performance data for AURA. This dashboard provides key metrics, financial ratios, and interactive charts to help you make informed investment decisions.

AURA

Aura Biosciences, Inc.

Healthcare
CEO: Elisabet de los Pinos
IPO: 2021-10-29
106 employees
$6.72
-0.28 (-4.17%)

Market Cap

417.45M

Enterprise Value

328M

Revenue (TTM)

0

Net Income

-86,919,000

P/E Ratio

-3.85x

ROE

-64.45%

Valuation Metrics
Market Cap
417M
Enterprise Value
328M
P/E Ratio
-3.85x
P/S Ratio
0.00x
P/B Ratio
2.23x
EV/Sales
0.00x
EV/FCF
-3.90x
Earnings Yield
-26.00%
FCF Yield
-20.18%
Price to Operating Cash Flow
-4.68x
Gross Margin
0.00%
Margin Metrics
Operating Margin
0.00%
Net Margin
0.00%
Pretax Margin
0.00%
ROIC
-26.48%
Dividends
Payout Ratio
0.00%
Dividend Yield
0.00%
Dividend per Share
$0.00
Return Metrics
ROE
-64.45%
ROCE
-26.93%
ROA
-49.60%
PEG Ratio
1.22x
Payout Ratio
0.00%
Financial Health
Debt to Assets
8.86%
Net Debt/EBITDA
1.77x
Growth Metrics
3Y Revenue Growth
0.00%
5Y Revenue Growth
0.00%
10Y Revenue Growth
0.00%
3Y Net Income Growth
-19.88%
5Y Net Income Growth
NaN%
10Y Net Income Growth
NaN%
3Y OCF Growth
-18.00%
5Y OCF Growth
NaN%
10Y OCF Growth
NaN%

Stock Performance

Interactive stock chart with historical price data and comparison tools. Analyze price movements, volume trends, and compare with other stocks or indices.

Loading chart data...